News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Biotech/Pharma - Alliances
Gilead Sciences, Inc. (GILD) to Allow Generic Drugmakers to Produce New Hep C Drug 1/26/2015
Yissum And Phytotech Medical To Collaborate On Novel Delivery System For Medical Cannabis 1/26/2015
Mylan Inc. (MYL) Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. (GILD) To Include Investigational Pan-Genotypic Agent 1/26/2015
NovaBay Pharmaceuticals, Inc. (NBY) Signs Avenova Distribution Agreement With Cardinal Health, Inc. (CAH) 1/26/2015
ImmuDyne, Inc. (IMMD) Teams With HellaWella 1/26/2015
Marketing And Distribution Partnership Renewed Between Healthcanal And UBM Medica US 1/26/2015
Lion Biotechnologies, Inc. Amends CRADA With National Cancer Institute To Develop TIL Therapy For Additional Cancer Indications 1/26/2015
Envisionrx And Gilead Sciences, Inc. (GILD) Sign Exclusive Agreement To Help In The Fight Against Hepatitis C 1/26/2015
Incyte Corporation (INCY) Earns $25 Million Milestone As Jakavi® (ruxolitinib) Recommended For Approval In Europe For Polycythemia Vera 1/23/2015
Immune Therapeutics, Inc. Announces Agreement With KRS Global Biotechnology, Inc. 1/23/2015
Celgene (CELG) Bets Big on Canada's Zymeworks 1/22/2015
Top CROs Like Quintiles, Inc. (Q) Stay Mum About Rumored Pfizer (PFE) Deal 1/22/2015
Curis, Inc. (CRIS), Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact 1/22/2015
Kite Pharma, Inc. (KITE) Announces Expanded Agreement With Tel Aviv Sourasky Medical Center And Pioneering Researcher Professor Zelig Eshhar To Develop Novel Chimeric Antigen Receptor (CAR) Approaches For Cancer Immunotherapy 1/22/2015
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015
Sigma-Aldrich Corporation (SIAL)™ And VIB Form Alliance To Provide Scientists With Enhanced And Faster Access To Novel Translational Research Tools 1/22/2015
ImmuPharma plc (IMM.L) Release: Landmark Collaboration Agreement & Commencement Of Pivotal Phase 3 Lupuzor™ Study With Simbec-Orion Deal Provides Powerful Validation For Lupuzor™ 1/22/2015
Contract Research Organization WCCT Global Announced As One Of Three Supporting Clinical Research Partners For DynPort Vaccine Company Development 1/22/2015
Cartagenia Partners With MedGenome To Provide Pathology Laboratories Access To Extensive Cancer Variant Knowledge Base 1/22/2015
New Oncology And University Hospital Oslo Announce Genomic Profiling Collaboration 1/22/2015
Johnson & Johnson (JNJ), Takeda (TKPYY) Open Up Israeli Biotech Incubator to Develop New Cures for Old Ills 1/21/2015
Massachusetts General Hospital’s Center For Integrated Diagnostics Utilizing InterSystems Corporation Technology For Genomics Research 1/21/2015
Arena Pharmaceuticals, Inc. (ARNA) Announces Agreement To Sell Common Stock 1/21/2015
PsychoGenics Inc. Obtains A License To The McGill Universityl-R-Thy1-APP Rat Model Of Alzheimer’s Disease 1/21/2015
Mitsubishi Gas Forms Asian Biologics CRO Partnership With Catalent 1/21/2015
IntelliCell BioSciences (SVFC) Announces Collaboration To Develop Closed Processing System For Cell Therapy Manufacturing 1/21/2015
Easton Pharmaceuticals (OP: EAPH) Is Pleased to Announce Definitive Finalized Agreement With Medicated Markets International LLC, A Major California Based Medical Marijuana Grower 1/21/2015
MedImmune (AZN) Establishes Three-Year Partnership With National Cancer Institute To Advance Oncology Research 1/21/2015
SYGNIS Signs Distribution Agreement With bioNova cientifica, s.l. For Its Innovative TruePrime™Single Cell WGA Kit In Spain 1/21/2015
TrovaGene, Inc. Expands Collaboration With Genomac To Demonstrate Clinical Utility In Lung And Colorectal Cancer Treatment Monitoring 1/21/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD) 1/20/2015
ABL Selected To Support Glioblastoma Multiforme Trial With Clinical Testing Services 1/20/2015
Cell Therapy Catapult And Trakcel To Collaborate On Research Project 1/20/2015
Celsion Corporation (CLSN) And myTomorrows Partner To Introduce Thermodox® Early Access Program In Europe For Patients With Recurrent Chest Wall Breast Cancer 1/20/2015
Tiziana Life Sciences Plc Licenses Milciclib From Nerviano Medical Sciences (NervianoMS) 1/20/2015
The Elton John AIDS Foundation Announces New Grant-Making Partnership With The Support Of The Elizabeth Taylor AIDS Foundation 1/20/2015
Kingworld Medicines Forms Marketing/Distribution Alliance With Sinopharm 1/20/2015
Evotec AG (EVTG.F) And C4X Discovery Enter Collaboration To Identify Pre-Clinical Development Candidates For Stress-Related Addictive Disorder Programme 1/19/2015
BMG Pharma S.r.l Grants The Exclusive Distribution Rights For Gelx® Oral Gel And Gelx® Spray For The Treatment Of Oral Mucositis In Cancer Patients To Ferrer Internacional 1/19/2015
Solasia Pharma K.K. And Meiji Seika Pharma Announce License And Collaboration Agreement For Darinaparsin (Intravenous Formulation) 1/19/2015
VECT-HORUS Announces The Signing Of A Scientific Collaboration Agreement With Sanofi (SAN.PA) 1/19/2015
Addex Therapeutics (ADXN.SW) And Dystonia Medical Research Foundation Announce Partnership To Explore The Therapeutic Use Of Dipraglurant In The Treatment Of Dystonia 1/19/2015
Genentech (RHHBY) Strikes DNA Sequencing Deal With Genome Pioneer Venter 1/16/2015
UCB SA, Neuropore to Develop Parkinson's Treatment in $480 Million Deal 1/16/2015
IXICO Selected As Imaging Analysis Partner Within The European Prevention Of Alzheimer’s Dementia Initiative (EPAD) 1/16/2015
Cell Therapy Catapult Licenses Nobel Prize-Winning Intellectual Property For Cell Bank 1/16/2015
MRIGlobal Wins $54 Million NIH Neurological Disorders And Stroke Contract To Support Drug Development 1/16/2015
Greengro Technologies Teams With Veridian Laboratories To Provide Advanced Testing Services For Agriculture And Cannabis 1/16/2015
Mayo Clinic And Hillhouse Form China Healthcare Delivery Venture 1/16/2015
23andMe is Sharing Users' Data Again, This Time With Pfizer (PFE) 1/15/2015
Optibrium And NextMove Software Announce Technology Collaboration 1/15/2015
Sanofi (SAN.PA), Boehringer Ingelheim Corporation Forge Biologics Pact 1/15/2015
Amarantus BioSciences, Inc. Announces Exclusive Option Agreement With Georgetown University To License Patent Rights For Blood Based Biomarkers For Alzheimer's Disease 1/15/2015
Evotec AG (EVTG.F) Achieves Further Milestones In TargetAD Collaboration With Janssen Pharmaceutical Inc. 1/15/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Contract Research Organization WCCT Global Announced Collaboration Agreement With The NIAID For Influenza Challenge Research 1/15/2015
Royal Philips Electronics N.V. (PHG) And Massachusetts Institute of Technology (MIT) Investigators Collaborate To Give Researchers Unprecedented Access To Critical Care Patient Data 1/15/2015
MD Anderson Cancer Center to Earn $100 Million From Intrexon Corporation and ZIOPHARM Oncology, Inc. (ZIOP.OB) for Immunotherapy Game-changer 1/14/2015
Another Day, Another $750 Million Antibiotic Deal for Roche (RHHBY) 1/14/2015
Neurobiopharm To Be Privatized By Neptune Technologies & Bioressources Inc. - Enters Into Arrangement Agreement With Neptune And Obtains Interim Order 1/14/2015
Vical Incorporated (VICL) And AnGes, Inc. Announce Collaboration To Develop Therapy For Ebola Virus Disease 1/14/2015
Oxford BioTherapeutics Grants An Exclusive License To Boehringer Ingelheim For Development And Commercialization Of Antibody Products To An Oncology Target 1/14/2015
Treeway Announces License And Collaboration Agreement With uniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS) 1/14/2015
National Research Council of Canada And KalGene Pharmaceuticals Announce License Agreement For The Development Of Novel Alzheimer's Therapeutics 1/14/2015
The Crohn's and Colitis Foundation of America And ResearchMatch Join Forces 1/14/2015
Optum Labs Research Collaborative Strengthens Collective Resource Base Through Addition Of Five Leading Organizations 1/14/2015
MedTech For Solutions Partners With NextGen LifeLabs 1/14/2015
Molplex Pharmaceuticals And AstraZeneca PLC (AZN) To Collaborate On New Oncology Research Programme 1/14/2015
Fair Access Medicines And Oncosynergy Partner To Test Experimental Ebola Drug In West Africa 1/14/2015
Coquí RadioPharmaceuticals Finalizes Agreement With University Of Florida Foundation For Land Transfer To Construct Medical Isotope Facility In Alachua County 1/14/2015
Boehringer Ingelheim Corporation And Vanderbilt University Join Forces To Develop New Ras Inhibitors For Cancer Treatment 1/14/2015
Isis Pharmaceuticals, Inc. (ISIS) Earns $7M for Advancing ISIS-SMN Rx In Children With Spinal Muscular Atrophy 1/14/2015
Omnicell And Pocket Nurse Announce Agreement To Provide State-Of-The-Art Medication Automation To Nurse Education Organizations 1/14/2015
Tianyin Pharmaceutical Co, Inc. To Form Strategic Alliance With Buchang Pharma 1/14/2015
Novartis AG (NVS), Qualcomm Launch $100 Million Fund for Innovative Health Startups 1/14/2015
Tiny Vedanta Biosciences Forges $241 Million+ Pact With Johnson & Johnson (JNJ) 1/14/2015
Merck & Co. (MRK) Jumps Into RNA Frenzy With $100 Million Bet on Moderna Therapeutics, Inc. 1/14/2015
Lockheed Martin Corporation And Illumina (ILMN) To Collaborate On Developing Genomics Solutions To Improve Public Health And Wellness 1/13/2015
Cellectis (ALCLS) And Ohio State University, Through The Ohio State Innovation Foundation, Enter Into Licensing Agreement For Chimeric Antigen Receptor Technology Targeting Multiple Myeloma 1/13/2015
Thermo Fisher Scientific (TMO) Signs Distribution Agreement With Cynvenio Biosystems, Inc. For LiquidBiopsy Platform 1/13/2015
Shanghai Biotech Forms Genomic CRO Alliance With AKESOgen, Inc. 1/13/2015
Nabsys And Ariana Pharma Collaborate To Identify DNA Structural Variants Linked To Targeted Cancers 1/13/2015
J.P. Morgan Breaking News: Novartis AG (NVS), Google Inc. (GOOG) to Team Up on "Smart" Contact Lens, Says CEO 1/13/2015
Therapix And Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing And Royalty Agreement 1/13/2015
Agios Pharmaceuticals (AGIO) Announces That Celgene (CELG) Has Agreed To Exercise Its Option To License AG-120 Under Global Strategic Collaboration 1/13/2015
Amgen (AMGN) And MD Anderson Cancer Center Announce Agreement To Develop Bite® Therapies For Myelodysplastic Syndrome 1/13/2015
Metanome, Inc. And Companion PBx Enter Into Strategic Partnership 1/13/2015
Bristol-Myers Squibb Company (BMY) And Eli Lilly (LLY) Enter Clinical Collaboration Agreement To Evaluate Opdivo (Nivolumab) In Combination With Galunisertib In Advanced Solid Tumors 1/13/2015
CureDuchenne Seeds Collaborative Project To Analyze The Natural History Of Duchenne Muscular Dystrophy 1/13/2015
New Partnership In Russia And CIS Further Expands Footprint For EffRx Proprietary Technologies 1/13/2015
Cord Blood Registry And Cellular Dynamics Announce Collaboration To Reprogram Newborn Stem Cells Into Induced Pluripotent Stem Cells 1/13/2015
Roche (RHHBY), Meiji And Fedora Pharmaceuticals Inc. Join Forces To Tackle Increasing Bacterial Resistance To Antibiotics 1/13/2015
Eli Lilly (LLY), Merck & Co. (MRK) Enter Collaboration Agreement To Research Immuno-Oncology Combination Regimens In Multiple Types Of Cancer 1/13/2015
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015
Johnson & Johnson (JNJ) Strikes $509 Million Alzheimer's Deal With AC Immune SA 1/12/2015
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Could Bank $1 Billion From Mundipharma AG, Purdue Pharma L.P. Pain Pact 1/12/2015
Gilead Sciences, Inc. (GILD) Throws Another Punch at AbbVie (ABBV) by Striking Deal With Anthem, Inc. 1/12/2015
Seattle Genetics, Inc. (SGEN) And Bristol-Myers Squibb Company (BMY) Announce Clinical Collaboration To Evaluate Combination Of Adcetris® (Brentuximab Vedotin) And Opdivo® (Nivolumab) In Hematologic Malignancies 1/12/2015
Enumeral Biomedical (ENUM) And Memorial Sloan-Kettering Cancer Center To Research Cancer Immunology With Advanced Prototype System For Human Tissue Immuno-Oncology Profiling 1/12/2015
Abzena Subsidiary Antitope, INSERM And Baylor Institute For Immunology Research To Collaborate To Produce Manufacturing Cell Lines For Two Novel Vaccines For HIV 1/12/2015
Kymab Partners With Cancer Immunotherapy Expert On Anti-Cancer Therapeutics 1/12/2015
MedImmune (AZN) Enters Licensing Agreement With Omnis Pharmaceuticals For Oncolytic Viruses In Immuno-Oncology 1/12/2015
Bionure And National Multiple Sclerosis Society Enter Into A Collaboration To Support The Development Of A New Chemical Entity For Optic Neuritis And Multiple Sclerosis 1/12/2015
NeoStem, Inc. And Invetech Announce Agreement To Develop Closed Processing System For Cell Therapy Manufacturing 1/12/2015
Boehringer Ingelheim Corporation And Yale University Collaborate To Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas 1/12/2015
Mersana Therapeutics, Inc., Takeda Pharmaceutical Co. Ltd. (TKPYY) Expand Antibody-Drug Pact By $300 Million 1/12/2015
HemoShear, LLC Announces Collaboration With Pfizer (PFE) To Help Identify And Predict Drug-Induced Vascular Injury For Early Stage Compounds 1/12/2015
Prasco Laboratories And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Into Agreement To Market Authorized Generic Of Colcrys® (Colchicine, USP) In The United States 1/12/2015
The Pancreatic Cancer Action Network And The National Cancer Institute's Frederick National Laboratory For Cancer Research Join Forces For Research Initiative 1/12/2015
MaRS Innovation Announces Collaboration With Johnson & Johnson (JNJ) Innovation And Janssen To Advance Cardiac, Diabetes And Depression Technologies 1/12/2015
TrovaGene, Inc. Collaborates With University of California, San Diego (UCSD) Moores Cancer Center To Demonstrate Clinical Utility Of Detecting And Monitoring EGFR Mutations In Lung Cancer Patients 1/12/2015
Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Agreement With Genovi Pharmaceuticals Limited For Development And Manufacturing Of Parenteral Drug Products 1/12/2015
23andMe Announces Collaboration With Pfizer (PFE) To Conduct Genetic Research Through 23andme's Research Platform 1/12/2015
Novella Clinical And The Cardiovascular Research Foundation Collaborate To Provide Comprehensive Clinical Trial Expertise 1/12/2015
Tokai Pharmaceuticals (TKAI) Provides Companion Diagnostic Update 1/12/2015
Adimab LLC. Announces Expansion Of Its Collaboration With GlaxoSmithKline (GSK) For The Discovery Of Bispecific Antibodies 1/12/2015
X-Chem Announces Collaboration With Janssen Pharmaceutical Inc. And Johnson & Johnson Innovation (JNJ) Innovation To Advance Novel Candidates To Treat Inflammatory Diseases 1/9/2015
Biogen Idec (BIIB) And Columbia University Medical Center To Conduct Collaborative Genetics Research 1/9/2015
Novartis AG (NVS) Strikes First-of-its-Kind Biotech Deal for Next Generation Drugs 1/9/2015
Adamas Pharmaceuticals (ADMS) Receives $30 Million Milestone Payment From Actavis (ACT) 1/9/2015
Nuo Therapeutics And ROHTO Pharmaceutical Co., Ltd. Sign Exclusive Licensing And Distribution Agreement For Aurix In Japan 1/9/2015
SinSa Labs Release: New Class Of Antibiotics - Bioengineered To Deter The Development Of Antibiotic Resistance 1/9/2015
Adimab LLC. Announces New Partnerships With Acceleron Pharma, Oncothyreon Inc. (ONTY), Surface Oncology And Potenza 1/9/2015
Fosun Pharma To Invest In Amerigen Pharmaceuticals 1/9/2015
University of California, San Diego (UCSD) Extension And San Diego Biotechnology Network Partner To Engage, Educate, And Empower Local Scientists 1/9/2015
Precision NanoSystems And Arcus Therapeutics, LLC Announce A Partnership For The Manufacture Of RNA Medicines 1/9/2015
Incyte Corporation (INCY), Agenus (AGEN) Strike $410 Million+ Immuno-Oncology Antibodies Pact 1/9/2015
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Eurofarma Laboratorios Enter Into Commercialization And Distribution Agreements For Delafloxacin In Brazil 1/8/2015
Shenzhen Hybio Pharma Sells US Rights For Generic MS Drug To Akorn, Inc. (AKN) 1/8/2015
Kite Pharma, Inc. (KITE) Announces Exclusive License With The NIH For T Cell Receptor (TCR)-Based Products To Treat HPV-Associated Cancers 1/8/2015
VBI Vaccines Partners With Le Classique To Raise CMV Awareness In Canada 1/8/2015
Glemser Technologies Partners With Benchworks; Unveils New Tech Features 1/8/2015
Syndax Pharmaceuticals Inc. Snags $125 Million Deal With Kyowa Hakko Kirin 1/8/2015
23andMe, Genentech (RHHBY) Forge $60 Million Parkinson's Research Deal 1/8/2015
TrovaGene, Inc. And City of Hope Collaborate To Monitor EGFR Mutational Status In Lung Cancer Patients 1/8/2015
MannKind Corporation (MNKD) Pockets $50 Million From Sanofi (SAN.PA) 1/8/2015
Stemline Therapeutics, Inc. (STML) In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1 1/8/2015
Helsinn And Pharmacosmos A/S Enter Into An Exclusive License Agreement For The Development And Commercialization Of Monofer® In US 1/8/2015
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property Related To The Treatment Of Huntington's Disease With Triheptanoin 1/8/2015
Egalet Acquires/Licenses Two Innovative Approved Pain Products 1/8/2015
H&P Labs Announces In-Licensing Agreement With Harvard University For Compounds To Develop Oral Ebola Treatment 1/8/2015
Biostar Pharmaceuticals, Inc. (BSPM) Announces Signing Of Joint Research And Development Agreement With Northwest University For Further Development Of Danshensu Yibingzhi (IDHP), A Class One Drug For Treatment Of Cardiovascular Diseases 1/8/2015
Musculoskeletal Transplant Foundation Signs Group Purchasing Agreement With Premier, Inc. 1/8/2015
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015
Repligen Corporation (RGEN) Receives Milestone Payment From Pfizer (PFE) 1/8/2015
ANGLE plc ("ANGLE" Or "The Company") Corporate Collaboration With Large Pharmaceutical Company 1/8/2015
MRC Technology To Manage Diabetes UK’s IP 1/8/2015
Proteros biostructures GmbH Enters Into A Collaboration With Bayer To Develop New Cardiovascular Drug Compounds For An Integral Membrane Protein 1/8/2015
Abcam plc (ABC.L) Signs Exclusive Partnership Agreement With A*STAR’s Institute Of Molecular And Cell Biology 1/8/2015
Mexichem Acquires The Distribution And Sale License For HFC-227ea/P Medical Propellant From Dupont Fluorochemicals 1/8/2015
Tiny Biotech Vtesse Nabs $25 Million and a Deal With the NIH 1/7/2015
Advaxis, Inc. And The GOG Foundation, Inc. To Collaborate On Global Phase 3 Clinical Trial Of ADXS-HPV In Cervical Cancer 1/7/2015
Evotec AG (EVTG.F) And Padlock Therapeutics Announce Initial Success And Extension Of Long-Term Collaboration 1/7/2015
GenSight Biologics, Pixium Vision And Fondation Voir Et Entendre Join Forces And Benefit From A Total € 18.5 Million Funding For SIGHT AGAIN As Part Of The Investment For The Future 1/7/2015
Reset Therapeutics Announces Expansion Of Its Drug Discovery Platform Via An Agreement With 23andMe Incorporating The Genetics Of Circadian Rhythms 1/7/2015
Addex Therapeutics (ADXN.SW) And NIAAA Enter Collaboration To Evaluate ADX71441 In Alcohol Use Disorder 1/7/2015
Swedish Orphan Biovitrum Extends And Restructures Distribution Agreement With Exelixis, Inc. (EXEL) For Cometriq 1/7/2015
Rush University Medical Center Selects Merge Healthcare (MRGE) Cardiology PACS 1/7/2015
Intellia Therapeutics, Novartis AG (NVS) Form Partnership To Develop New Cell Therapies Using CRISPR/Cas9 Technology 1/7/2015
Caribou Biosciences Announces New Research Collaboration And Equity Investment Agreements With Novartis AG (NVS) 1/7/2015
Tetragenetics, Inc. Collaborates With MedImmune (AZN) On Multi-Target Ion Channel Drug Discovery Program 1/7/2015
Exelixis, Inc. (EXEL) And Swedish Orphan Biovitrum Extend And Restructure Distribution Agreement For COMETRIQ® For Medullary Thyroid Cancer 1/7/2015
The Multiple Myeloma Research Foundation (MMRF) And GNS Healthcare Announce Collaboration To Identify Potential New Multiple Myeloma Therapies 1/7/2015
Isis Pharmaceuticals, Inc. (ISIS) Rockets as Johnson & Johnson (JNJ) Snags Bowel Drug License Option for $835 Million 1/7/2015
Symplmed Brings VAYA Pharma Products Into Dyrctaxess Technology® 1/7/2015
Interleukin Genetics Inc. (ILGN) Announces Collaboration With Isis Pharmaceuticals, Inc. (ISIS) For Genetic Testing Services 1/7/2015
Qualcomm Announces Strategic Collaboration With Novartis AG (NVS) To Optimize Global Clinical Trials 1/6/2015
Paratek Pharmaceuticals, Inc. To Receive $4 Million Payment From Actavis (ACT) With Initiation Of Phase 3 Trial Of Sarecycline 1/6/2015
Argos Therapeutics, Inc. (ARGS) And Saint-Gobain Performance Plastics Announce Agreement For Production Of Disposables Used In Automated Manufacturing Of Fully Personalized Immunotherapies 1/6/2015
Vectura Group plc (VEC.L) Signs Global Development And Licence Agreement With Janssen Biotech Inc. (JNJ) In Asthma/COPD 1/6/2015
CAPNIA, Inc. And Clinvest® Partner To Develop Cluster Headache Therapeutic 1/6/2015
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK) Turn to Crowd-Funding Experiment to Reinvigorate Slumping Pipeline 1/6/2015
Amgen (AMGN), Kite Pharma, Inc. (KITE) Forge $1 Billion+ Cancer Immunotherapy Pact 1/6/2015
Boehringer Ingelheim Corporation And BioMed X Collaborate To Discover New Epigenetic Regulators Of COPD 1/5/2015
Bay Area's Amunix, Inc. Strikes $70 Million+ Deal With Naia 1/5/2015
Symic Biomedical Announces Collaboration With Nordic Bioscience A/S For Its Osteoarthritis Program 1/5/2015
Onco360 Chosen By Bayer AG (BAYZF) As Limited Distribution Pharmacy Provider 1/5/2015
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015
New Jobs on the Horizon as Illuminating Diagnostics, NomoCan Pharma and ProGen Life Sciences Make Move to NY's Tax-Free Campuses 1/2/2015
United Therapeutics Corporation (UTHR) Announces Signing Of Agreement For New Remodulin Delivery System 12/31/2014
Easton Pharmaceuticals (OP: EAPH) Announces Signed Agreement With Medicated Markets International LLC, A Major California-Based Medical Marijuana Grower 12/31/2014
Pozen, Inc. (POZN) Terminates Another Deal; This Time With Johnson & Johnson (JNJ) 12/30/2014
Tikcro Technologies Signs Research And License Agreement Regarding Cancer Immune Checkpoint Antibodies 12/30/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercialization Agreement For Iclusig In Seven Central And Eastern European Countries 12/30/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Snags $27 Million and Prostate/Lung Cancer Rights From Teva Pharmaceutical Industries Limited (TEVA) 12/30/2014
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact 12/29/2014
PPD, Inc. (PPDI) And Shin Nippon Biomedical Laboratories Announce Japanese Clinical Development Joint Venture And Additional Collaborations 12/29/2014
LCS Therapeutics And Lucerne Biosciences To Commercialize '813 Patent For Lisdexamfetamine Dimesylate In The Treatment Of Binge Eating Disorder 12/29/2014
AMAG Pharmaceuticals, Inc. (AMAG), Takeda (TKPYY) Abandon $280 Million Ferumoxytol Pact 12/29/2014
Johnson & Johnson (JNJ) Bets $700 Million on MacroGenics, Inc. (MGNX)'s Blood Cancer Drug 12/24/2014
Amgen (AMGN) Sponsors Biotech Incubator in MA to Support Biotech Startups 12/24/2014
SSF's Cytokinetics, Inc. (CYTK) Snags $675 Million+ Deal With Astellas Pharma Inc. (ALPMY) 12/24/2014
BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma 12/24/2014
PPD, Inc. (PPDI) And SNBL Announce Japanese Clinical Development Joint Venture And Additional Collaborations 12/24/2014
Medivation, Inc. (MDVN) Exercises License Option For Pidilizumab 12/24/2014
Novozymes Biopharma Enters License Agreement With EpiVax, Inc. To Advance Pioneering Treatment Of Autoimmune Diseases 12/23/2014
Selecta Biosciences, Inc. And Skolkovo Foundation Collaboration To Develop A Synthetic Vaccine Particle In The Field Of Immuno-Oncology 12/23/2014
EB Pharma Announces License Agreement For Investigational Drug, Tipifarnib From Janssen Pharmaceutica N.V. For Development In Hepatitis Delta Virus (HDV) Infection 12/23/2014
China Pioneer Extends Marketing Relationships With Polichem 12/23/2014
MA's Ariad Pharmaceuticals, Inc. (ARIA) Inks $75 Million+ Commercialization Deal In Asia 12/23/2014